Data from rats with TP-induced BPH showed the upregulation of cyclin A, Cdk2, cyclin D1, and Cdk6 protein expression, whereas administration of Fina and 6SL reduced the expression of cyclin–Cdk complexes (Figure 3C). The gene discussed is CDK2; the disease is benign prostatic hyperplasia.